Scientists have taken the first steps to developing a vaccine for chikungunya — an emerging mosquito-borne virus that has infected more than a half million people in the Western Hemisphere this year. About 600 Americans have brought the virus to 43 states.
The study was small. Only 25 people ... Read More
Explorations of how the microscopic communities that inhabit the human body might contribute to health or disease have moved from obscure to ubiquitous. Over the past five years, studies have linked our microbial settlers to conditions as diverse as autism, cancer and diabetes.
This excitemen... Read More
West Africa's Ebola epidemic, the deadliest on record, presents particular challenges for medical staff. Here, Irish doctor Gabriel Fitzpatrick describes working for Medecins Sans Frontieres (MSF) at the centre of the outbreak in Sierra Leone:
MSF constructed a special Ebola treatment centre ... Read More
Enhancing the discoverability of public health and epidemiology research data is a key to ensuring that it gets more widely used. This was the topic of a recent workshop hosted by the London School of Hygiene and Tropical Medicine, where researchers and data experts explored the findings of a re... Read More
Investigators at the University of Southampton have discovered that two new vaccines can prevent the transmission of meningitis bacteria from person to person.
The vaccines do this by reducing ‘carriage’ of the responsible bacteria in the nose and throats of the population.
Meningitis is... Read More
A group of researchers at the Max F. Perutz Laboratories has created one of the three world's largest gene libraries for the Candida glabrata yeast, which is harmful to humans. Molecular analysis of the Candida glabrata fungus mutations led to the discovery of 28 new genes that are partly respon... Read More